Market Intelligence

Corporate compliance programs traditionally focus on reporting misconduct after it occurs, but what if employees could prevent harm before it happens? Active bystandership offers organizations a proactive approach to risk reduction by equipping employees with practical intervention skills and organizational support, transforming compliance from reactive reporting to preventive action.

Trade compliance teams face mounting expectations but often lack the resources to match. This episode explores what it takes to move from constant firefighting to genuine trade readiness...

Hardware is hard, and financing hardware is harder. The product is physical, the development cycle is long, the capital requirements are front-loaded into machines and prototypes, and revenue often arrives only after a pilot deployment proves the system works in a customer’s facility. Those realities shape every financing decision a robotics founder makes, from the first dollar of personal savings through preferred equity rounds and the debt facilities layered alongside them.

The U.S. IPO market is no longer frozen for life sciences companies; it is open, albeit selectively. A track record of strong 2026 IPOs is bringing credible issuers back to market, but investors are still demanding maturity, data and discipline. At the same time, the SEC’s pending registered offering and filer-status reforms could give newly public life sciences companies a materially better capital raising toolkit, if adopted, and provide additional tailwinds to the market.

When public allegations surface before an investigation concludes, organizations face a critical challenge: managing the period between accusation and resolution without creating additional legal or reputational problems. How should companies respond publicly while preserving investigative integrity and avoiding premature conclusions that could complicate litigation, regulatory scrutiny, or employment claims?

Arnold & Porter's Consumer Products & Retail Industry Group presents a comprehensive webinar examining the critical regulatory challenges that can determine the success or failure of M&A transactions in the consumer products and retail sectors. The program explores how state regulations, antitrust considerations, AI governance uncertainties, and privacy litigation are fundamentally reshaping deal structures and diligence requirements. Industry leaders will provide actionable insights on navigating dynamic p